It is well-documented that adiponectin is the most abundant peptide secreted by adipocytes, whose increases are considered a therapeutic target in obesity-related diseases, including insulin resistance and T2DM (109, 110). This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.